Jaeb Center for Health Research, Tampa, Florida 33647, USA.
Foundation Fighting Blindness, Columbia, Maryland 21045, USA.
Cold Spring Harb Perspect Med. 2023 Mar 1;13(3):a041297. doi: 10.1101/cshperspect.a041297.
Natural history studies of inherited retinal diseases (IRDs) play a critical role in the design and implementation of treatment trials. Study objectives ideally encompass (1) understanding the time course and pattern of disease progression, (2) within genotypic and phenotypic subtypes of patient populations, and (3) characterizing a range of measures of vision function, retinal structure, and functional vision that may serve as endpoints. In rare disease, data quality standards are paramount to optimizing smaller sample sizes, including a prospective, standardized, and longitudinal approach to data collection. Multicenter studies additionally facilitate strength in numbers and generalizability, and multidisciplinary collaboration ensures a holistic approach to study design and knowledge-building. Dissemination of natural history study results, data sets, and lessons learned will stimulate further innovation and progress in IRD therapeutic research, including setting up future trial designs for their best chance of success.
遗传性视网膜疾病(IRDs)的自然史研究在治疗试验的设计和实施中起着至关重要的作用。研究目标理想情况下包括:(1)了解疾病进展的时间过程和模式;(2)在患者人群的基因型和表型亚型内;(3)描述一系列视觉功能、视网膜结构和功能视力的测量指标,这些指标可作为终点。在罕见疾病中,数据质量标准对于优化较小的样本量至关重要,包括前瞻性、标准化和纵向的数据收集方法。多中心研究还可以增加数量和通用性,多学科合作确保对研究设计和知识构建采用整体方法。自然史研究结果、数据集和经验教训的传播将激发 IRD 治疗研究的进一步创新和进展,包括为未来试验设计制定最佳成功机会。